Reconsideration of Anticoagulant Therapy in Japanese Patients With Atrial Fibrillation and Moderate Renal Impairment

被引：0
作者：
Shiga, Tsuyoshi [1 ]
机构：
[1] Tokyo Womens Med Univ, Dept Cardiol, Tokyo 1628666, Japan
来源：
CIRCULATION JOURNAL | 2013年 / 77卷 / 03期
关键词：
GLOMERULAR-FILTRATION-RATE; WARFARIN; RIVAROXABAN; RISK; STROKE; DABIGATRAN; APIXABAN; EFFICACY; SAFETY;
D O I：
10.1253/circj.CJ-13-0066
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 15 条
  • [1] Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation The Atherosclerosis Risk in Communities (ARIC) Study
    Alonso, Alvaro
    Lopez, Faye L.
    Matsushita, Kunihiro
    Loehr, Laura R.
    Agarwal, Sunil K.
    Chen, Lin Y.
    Soliman, Elsayed Z.
    Astor, Brad C.
    Coresh, Josef
    [J]. CIRCULATION, 2011, 123 (25) : 2946 - U81
  • [2] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [3] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
    Fox, Keith A. A.
    Piccini, Jonathan P.
    Wojdyla, Daniel
    Becker, Richard C.
    Halperin, Jonathan L.
    Nessel, Christopher C.
    Paolini, John F.
    Hankey, Graeme J.
    Mahaffey, Kenneth W.
    Patel, Manesh R.
    Singer, Daniel E.
    Califf, Robert M.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2387 - 2394
  • [4] Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Go, Alan S.
    Fang, Margaret C.
    Udaltsova, Natalia
    Chang, Yuchiao
    Pomernacki, Niela K.
    Borowsky, Leila
    Singer, Daniel E.
    [J]. CIRCULATION, 2009, 119 (10) : 1363 - 1369
  • [5] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [6] Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment
    Hariharan, Sudharshan
    Madabushi, Rajanikanth
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 : 119S - 125S
  • [7] Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Hohnloser, Stefan H.
    Hijazi, Ziad
    Thomas, Laine
    Alexander, John H.
    Amerena, John
    Hanna, Michael
    Keltai, Matyas
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose
    Granger, Christopher B.
    Wallentin, Lars
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (22) : 2821 - 2830
  • [8] Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation - Subanalysis of J-ROCKET AF for Patients With Moderate Renal Impairment
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    [J]. CIRCULATION JOURNAL, 2013, 77 (03) : 632 - 638
  • [9] Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    [J]. CIRCULATION JOURNAL, 2012, 76 (09) : 2104 - 2111
  • [10] Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
    Kubitza, Dagmar
    Becka, Michael
    Mueck, Wolfgang
    Halabi, Atef
    Maatouk, Haidar
    Klause, Norbert
    Lufft, Volkmar
    Wand, Dominic D.
    Philipp, Thomas
    Bruck, Heike
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (05) : 703 - 712
12